MedPath

Effects of Supplement Containing Various Probiotics and Fermentation Products on Obesity

Not Applicable
Completed
Conditions
Obesity
Registration Number
NCT00880958
Lead Sponsor
Hiroshima University
Brief Summary

The purpose of this study is to determine the effect of supplement combined various probiotics and fermentation products on body mass index, body fat mass, abdominal circumference, visceral fat mass, intestinal flora, and serum biochemical parameters in overweight subjects.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • Healthy as based on medical history and physical examination
  • BMI between 25 and 30 kg/m2
  • Willing not to serve as blood donor during the study
  • Informed consent signed
Exclusion Criteria
  • Food allergy
  • Female subjects who are pregnant or nursing a child
  • Participation in any clinical trial up to 90 days before Day 01 of this study
  • Renal or hepatic dysfunction
  • Heart disease
  • Under medication
  • Subjects who are taking functional food designed for weight loss or serum lipid reduction

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Body mass index16 weeks
Secondary Outcome Measures
NameTimeMethod
Body fat massWeek -4, Week 0, Week 4, Week 12
Abdominal circumferenceWeek -4, Week 0, Week 4, Week 12
Visceral fat area by CT scanWeek 0, Week 12
Intestinal floraWeek 0, Week 12
Serum lipid profileWeek -4, Week 0, Week 4, Week 12
Serum adiponectin and leptin levelsWeek 0, Week 12
Fasting serum glucose and HbA1c levelsWeek -4, Week 0, Week 4, Week 12

Trial Locations

Locations (1)

Hiroshima University

🇯🇵

Hiroshima, Japan

Hiroshima University
🇯🇵Hiroshima, Japan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.